# Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

> **NCT04419337** · PHASE2 · UNKNOWN · sponsor: **Chang Gung Memorial Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Diabetes Mellitus
- Stroke

## Interventions

- **DRUG:** Metformin plus Pioglitazone plus an SGLT2 inhibitor

## Key facts

- **NCT ID:** NCT04419337
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-15
- **Primary completion:** 2023-07-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-03-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04419337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04419337, "Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04419337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*